CO4520230A1 - Derivados de [3-(4-fenilpiperacin-1-il) propilamino, tio y oxilo]-piridina, pirimidina y benceno como antagonistas de alfa 1- adrenoceptores - Google Patents
Derivados de [3-(4-fenilpiperacin-1-il) propilamino, tio y oxilo]-piridina, pirimidina y benceno como antagonistas de alfa 1- adrenoceptoresInfo
- Publication number
- CO4520230A1 CO4520230A1 CO95052482A CO95052482A CO4520230A1 CO 4520230 A1 CO4520230 A1 CO 4520230A1 CO 95052482 A CO95052482 A CO 95052482A CO 95052482 A CO95052482 A CO 95052482A CO 4520230 A1 CO4520230 A1 CO 4520230A1
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- halo
- alkyloxyl
- ilo
- hydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
REIVINDICACION NUMERO UN COMPUESTO DE LA FORMULA I FIGURA 1 EN DONDE p ES 0 o 1; t ES 0, 1 o 2; x es 0, S o NR6 (EN DONDE R6 ES HIDRO o (C1-6)AL- QUILO; Y y Z SON INDEPENDIENTEMENTE CH o N; R7 ES HIDRO, HIDROXILO, HALO, NITRO, AMINO, CIANO, (C1-4)-ALQUILTIO, ACETILAMINO, TRIFLUOROACETILAMI- NO, METILSULFONILAMINO,(C1-6)ALQUILO, C3-6)CICLO- ALQUILO,(C3-6)CILCOALQUILL-(C1-4)ALQUILO, OXAZOL- 2-ILO, ARILO, HETEROARILO, ARIL-(C1-4)-ALQUILO, HETEROARIL(C1-4)ALQUILO, (C1-6)ALQUILOXILO, (C3-6) CICLO-ALQUILOXILO, (C3-6)CICLOALQUIL (C1-4)ALQUI- LOXILO, 2-PROPINILOXILO, ARILOXILO, HETEROARILOXI- LO, ARIL(C1-4)ALQUILOXILO O HETEROARIL(C1-4) AL- QUILOXILO (EN DONDE ALQUILO ESTA OPCIONALMENTE SUSTITUIDO POR UNO O TRES ATOMOS DE HALO Y ARILO O HETEROARILO ESTA OPCIONALMENTE SUSTITUIDO POR UNO O DOS SUSTITUYENTES ELEGIDOS INDEPENDIENTEMENTE ENTRE HALO Y CIANO); R2 ES HIDRO, HIDROXILO, HALO, CIANO, (C1-6) ALQUI- LO O (C1-6)-ALQUILOXILO (EN DONDE ALQUILO ESTA OPCIONALMENTE SUSTITUIDO POR UNO O TRES ATOMOD DE HALO); R3 ES -C(O)R7 (EN DONDE R7 ES (C1-6) ALQUILO, (C3-6)CICLOALQUILO, DI(C1-4) ALQUILAMINO, N-(C1-4) ALQUIL-N-(C1-4)ALQUILOXIAMINO, (C1-4)ALQUIL(C1-4) ALQUILOXI)AMINO, PIRROLIDIN-1-ILO, PIPERIDIN-1- ILO, MORFOLIN-4-ILO o PIPERACION-1-ILO; R4 ES HALO, HIDROXILO, CIANO, (C1-6)ALQUILO O (C1-6)ALQUILOXILO; Y R5 ES (C1-6)ALQUILO; Y LAS SALES FARMACEUTICA- MENTE ACEPTABLES Y SUS N-OXIDOS".
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/336,368 US5688795A (en) | 1994-11-08 | 1994-11-08 | 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4520230A1 true CO4520230A1 (es) | 1997-10-15 |
Family
ID=23315765
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO95052482A CO4520230A1 (es) | 1994-11-08 | 1995-11-07 | Derivados de [3-(4-fenilpiperacin-1-il) propilamino, tio y oxilo]-piridina, pirimidina y benceno como antagonistas de alfa 1- adrenoceptores |
Country Status (22)
Country | Link |
---|---|
US (1) | US5688795A (es) |
EP (1) | EP0711757A1 (es) |
JP (1) | JPH08208614A (es) |
KR (1) | KR960017658A (es) |
CN (1) | CN1136039A (es) |
AR (1) | AR002244A1 (es) |
AU (1) | AU3459995A (es) |
BR (1) | BR9505107A (es) |
CA (1) | CA2162089A1 (es) |
CO (1) | CO4520230A1 (es) |
CZ (1) | CZ291095A3 (es) |
FI (1) | FI955376A (es) |
HU (1) | HUT73843A (es) |
IL (1) | IL115844A0 (es) |
MA (1) | MA23717A1 (es) |
NO (1) | NO954453L (es) |
NZ (1) | NZ280396A (es) |
PE (1) | PE10997A1 (es) |
PL (1) | PL311261A1 (es) |
SG (1) | SG70950A1 (es) |
TR (1) | TR199501387A2 (es) |
ZA (1) | ZA959268B (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4425143A1 (de) | 1994-07-15 | 1996-01-18 | Basf Ag | Substituierte Pyrimidinverbindungen und deren Verwendung |
EA001904B1 (ru) | 1997-05-12 | 2001-10-22 | ОРТО МакНЕЙЛ ФАРМАСЬЮТИКАЛ, ИНК. | Арилзамещенные пиперазины для лечения доброкачественной гиперплазии простаты |
DE19728996A1 (de) | 1997-07-07 | 1999-01-14 | Basf Ag | Triazolverbindungen und deren Verwendung |
US6271234B1 (en) | 1997-08-01 | 2001-08-07 | Recordati S.A., Chemical And Pharmaceutical Company | 1,4-disubstituted piperazines |
IT1293807B1 (it) * | 1997-08-01 | 1999-03-10 | Recordati Chem Pharm | Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico |
US20020193383A1 (en) * | 1997-08-01 | 2002-12-19 | Recordati S.A., Chemical And Pharmaceutical Comoany | 1-(N-phenylalkylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring |
US6399614B1 (en) | 1997-08-01 | 2002-06-04 | Recordati S.A. Chemical And Pharmaceutical Company | 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring |
IT1293804B1 (it) * | 1997-08-01 | 1999-03-10 | Recordati Chem Pharm | Diarilalchilpiperazine attive sulle basse vie urinarie |
ZA991315B (en) * | 1998-02-20 | 2000-11-20 | Ortho Mcneil Pharm Inc | Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia. |
US7045519B2 (en) * | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
DE69919707T2 (de) | 1998-06-19 | 2005-09-01 | Chiron Corp., Emeryville | Glycogen synthase kinase 3 inhibitoren |
US6465467B1 (en) | 1999-05-21 | 2002-10-15 | Biovitrum Ab | Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
US6355801B1 (en) * | 1999-11-08 | 2002-03-12 | Schering Corporation | Process for preparing N-(4-hydroxyphenyl)-N′-(4′-aminophenyl)-piperazine |
AU1529402A (en) | 2000-11-20 | 2002-05-27 | Biovitrum Ab | Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor |
CZ20031698A3 (cs) | 2000-11-30 | 2003-11-12 | Ranbaxy Laboratories Limited | 1,4-Disubstituované piperazinové deriváty využitelné jako uro-selektivní alfa1-adrenoreceptorové blokátory |
BR0311970A (pt) | 2002-06-19 | 2005-03-29 | Biovitrum Ab | Novos compostos, seu uso e preparação |
UA89035C2 (ru) * | 2003-12-03 | 2009-12-25 | Лео Фарма А/С | Эфиры гидроксамовых кислот и их фармацевтическое применение |
MY140489A (en) * | 2003-12-26 | 2009-12-31 | Eisai R&D Man Co Ltd | 1,2-di (cyclic) substituted benzene compounds |
US20070219213A1 (en) * | 2004-05-20 | 2007-09-20 | Soares Romeiro Luiz A | Use of Adrenergic N-Phenylpiperazine Antagonists, Pahrmaceutical Compositions Containning Them, and Methods of Preparing Them |
US8470859B2 (en) * | 2006-10-23 | 2013-06-25 | Takeda Pharmaceutical Company Limited | Iminopyridine derivative and use thereof |
EP2202228B1 (en) * | 2007-10-15 | 2014-12-10 | Takeda Pharmaceutical Company Limited | Amide compounds and use of the same |
BRPI0910737A2 (pt) * | 2008-04-23 | 2019-09-24 | Takeda Pharmaceuticals Co | composto, pró-droga, agente farmacêutico, método para profilaxia ou tratamento de doenças do trato urinário inferior em um mamífero, e, uso de um composto ou uma pró-droga do mesmo. |
US8481569B2 (en) | 2008-04-23 | 2013-07-09 | Takeda Pharmaceutical Company Limited | Iminopyridine derivatives and use thereof |
US20110039892A1 (en) * | 2008-04-23 | 2011-02-17 | Takeda Pharmaceutical Company Limited | Iminopyridine derivative and use thereof |
CN101585781B (zh) * | 2009-07-08 | 2012-08-08 | 北京颖新泰康国际贸易有限公司 | 一种邻氨基-n,n-二甲基苯甲酰胺的制备方法 |
CN103387531A (zh) * | 2012-05-10 | 2013-11-13 | 广州医学院 | 酰胺类芳基哌嗪衍生物及其制备方法和在抗良性前列腺增生中的应用 |
CN114163383A (zh) * | 2021-12-24 | 2022-03-11 | 江苏丰山集团股份有限公司 | 一种烟嘧磺隆中间体烟酰胺和磺酰胺的绿色生产工艺 |
CN115611802B (zh) * | 2022-12-02 | 2023-03-14 | 北京迪泰医药科技有限公司 | 一种3-乙酰基-2-氯吡啶的合成方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3635976A (en) * | 1967-12-20 | 1972-01-18 | Pennwalt Corp | 1 - heterocyclic alkyl-1 2 3 4-tetrahydroquinazolinones and analgesic intermediates thereof |
BE787126A (fr) * | 1971-08-04 | 1973-02-05 | Byk Gulden Lomberg Chem Fab | Pyrimidines substituees, procedes de preparation de ces composes et medicaments contenant lesdits composes |
DE2143730A1 (de) * | 1971-09-01 | 1973-03-08 | Byk Gulden Lomberg Chem Fab | Substituierte pyridine, verfahren zu deren herstellung und sie enthaltende arzneimittel |
JPS49133380A (es) * | 1973-04-25 | 1974-12-21 | ||
US4616017A (en) * | 1984-06-04 | 1986-10-07 | Merck & Co., Inc. | Aminohydroxypropoxy substituted aryl compounds |
GB2163150B (en) * | 1984-07-19 | 1988-05-25 | Sandoz Ltd | 3-aminopropoxyaryl derivatives |
FR2656609B1 (fr) * | 1989-12-28 | 1992-03-27 | Synthelabo | Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique. |
FR2678272B1 (fr) * | 1991-06-27 | 1994-01-14 | Synthelabo | Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique. |
-
1994
- 1994-11-08 US US08/336,368 patent/US5688795A/en not_active Expired - Fee Related
-
1995
- 1995-10-27 EP EP95116942A patent/EP0711757A1/en not_active Withdrawn
- 1995-11-01 IL IL11584495A patent/IL115844A0/xx unknown
- 1995-11-01 AU AU34599/95A patent/AU3459995A/en not_active Abandoned
- 1995-11-01 SG SG1995001704A patent/SG70950A1/en unknown
- 1995-11-02 ZA ZA9509268A patent/ZA959268B/xx unknown
- 1995-11-03 CA CA002162089A patent/CA2162089A1/en not_active Abandoned
- 1995-11-03 NZ NZ280396A patent/NZ280396A/en unknown
- 1995-11-06 PE PE1995283893A patent/PE10997A1/es not_active Application Discontinuation
- 1995-11-06 AR ARP950100065A patent/AR002244A1/es unknown
- 1995-11-06 CN CN95118772A patent/CN1136039A/zh active Pending
- 1995-11-06 HU HU9503178A patent/HUT73843A/hu unknown
- 1995-11-07 CO CO95052482A patent/CO4520230A1/es unknown
- 1995-11-07 JP JP7287753A patent/JPH08208614A/ja active Pending
- 1995-11-07 NO NO954453A patent/NO954453L/no unknown
- 1995-11-07 BR BR9505107A patent/BR9505107A/pt not_active Application Discontinuation
- 1995-11-07 CZ CZ952910A patent/CZ291095A3/cs unknown
- 1995-11-07 PL PL95311261A patent/PL311261A1/xx unknown
- 1995-11-08 TR TR95/01387A patent/TR199501387A2/xx unknown
- 1995-11-08 FI FI955376A patent/FI955376A/fi unknown
- 1995-11-08 KR KR1019950040349A patent/KR960017658A/ko not_active Application Discontinuation
- 1995-11-08 MA MA24062A patent/MA23717A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
BR9505107A (pt) | 1997-09-09 |
PL311261A1 (en) | 1996-05-13 |
CZ291095A3 (en) | 1996-09-11 |
JPH08208614A (ja) | 1996-08-13 |
MA23717A1 (fr) | 1996-07-01 |
HU9503178D0 (en) | 1996-01-29 |
FI955376A (fi) | 1996-05-09 |
NO954453D0 (no) | 1995-11-07 |
KR960017658A (ko) | 1996-06-17 |
AU3459995A (en) | 1996-05-16 |
NZ280396A (en) | 1997-05-26 |
PE10997A1 (es) | 1997-04-26 |
ZA959268B (en) | 1997-01-31 |
SG70950A1 (en) | 2000-03-21 |
EP0711757A1 (en) | 1996-05-15 |
HUT73843A (en) | 1996-09-30 |
IL115844A0 (en) | 1996-01-31 |
NO954453L (no) | 1996-05-09 |
CN1136039A (zh) | 1996-11-20 |
AR002244A1 (es) | 1998-03-11 |
TR199501387A2 (tr) | 1996-07-21 |
FI955376A0 (fi) | 1995-11-08 |
CA2162089A1 (en) | 1996-05-09 |
US5688795A (en) | 1997-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO4520230A1 (es) | Derivados de [3-(4-fenilpiperacin-1-il) propilamino, tio y oxilo]-piridina, pirimidina y benceno como antagonistas de alfa 1- adrenoceptores | |
MD420C2 (ro) | Derivaţi ai acidului acrilic | |
DE3789967D1 (de) | Anwendung von monoaminakridinen bei mangelerscheinungen des cholinergen nervensystems. | |
ES2139676T3 (es) | Pirazoles sustituidos como antagonistas del crf. | |
ES2101429T3 (es) | Derivados de triazolopirimidina con actividad fungicida. | |
AR009321A1 (es) | Compuestos derivados de 6,6-heterobiciclicos sustituidos y composiciones farmaceuticas que los contienen y compuestos intermediarios. | |
DE68922044D1 (de) | 2,4-Diamino-pyrimidin-3-oxid-Derivate und deren Verwendung bei der Behandlung und zur Verhütung von Haarfall. | |
DE59207226D1 (de) | Pharmakologisch wirksame Hydrazinderivate und Verfahren zu deren Herstellung | |
ES2039361T3 (es) | Derivados de 3-vinil- y 3-etinil-beta-carbolinas, su preparacion y su utilizacion como medicamentos. | |
FI935753A (fi) | Retrovirusten vastaiset hydratsiinijohdannaiset | |
AR039172A1 (es) | Derivados de morfolina, antagonistas de ccr3. | |
DK1034174T3 (da) | Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer | |
ATE48999T1 (de) | Piperazin-1-yl-ergolinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
IT1241988B (it) | 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono | |
ES8502699A1 (es) | Procedimiento para la obtencion de tetrahidrotiopiran-3, 5-dion-4-carboxamidas | |
DE3569377D1 (de) | Benzodisultame | |
ES2147316T3 (es) | 1-cicloalqueniltetrazolinonas. | |
ES2190130T3 (es) | Uretanos derivados de azacicloalcanos, sus analogos tio y ditio, su preparacion y su empleo como inhibidores de 2,3-epoxiescualeno-lanosterol-ciclasa. | |
FR2633622B1 (fr) | Derives de sulfonyl indolizine, leur procede de preparation et leur utilisation comme intermediaires de synthese | |
AR007463A1 (es) | Colorantes monoazoicos sustituidos por grupos haloalquilcarbamato y sulfonilfluoruro | |
ES2080485T3 (es) | Aminoalcoholes utiles como agentes resolventes opticos. | |
CO4940508A1 (es) | 2,4-diaminopirimidina substituida | |
ECSP961783A (es) | Derivados de pirimidindiona pirimidintriona triacindiona tetrahidro- quinazolindion como antagonistas adrenoceptores case ran 4013/26 | |
ATE71367T1 (de) | Verfahren zur herstellung von indolinen. | |
OA07324A (fr) | Oximino-acétonilides, leur procédé de production ainsi que leur utilisation comme pesticides. |